| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |



,
From the Division of Laboratory Medicine,
*
Department of Pathology,
and the Departments of Surgery
and Pediatrics,
Washington University School of Medicine and St. Louis Childrens Hospital, St. Louis, Missouri
The fragile X syndrome is the most commonly inherited cause of mental retardation. Genetic diagnosis of this disease relies on the detection of triplet repeat expansion in the FMR1 gene on the X chromosome. Although the majority of disease in fragile X patients is due to mutations involving triplet repeat expansion, deletion of various portions of FMR1 has also been described in association with the fragile X syndrome. Here we describe a rare polymorphism in the noncoding region of FMR1 that mimics detection of a deletion in a commonly used assay for fragile X syndrome, which can result in misdiagnosis of the disease.
This article has been cited by other articles:
![]() |
S. Liang, H. N. Bass, H. Gao, C. Astbury, M. R. Jamehdor, and Y. Qu A Pseudo-Full Mutation Identified in Fragile X Assay Reveals a Novel Base Change Abolishing an EcoRI Restriction Site J. Mol. Diagn., September 1, 2008; 10(5): 469 - 474. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Cecconi, F. Forzano, R. Rinaldi, S. Cappellacci, P. Grammatico, F. Faravelli, F. Dagna Bricarelli, E. Di Maria, and M. Grasso A Single Nucleotide Variant in the FMR1 CGG Repeat Results in a "Pseudodeletion" and Is Not Associated with the Fragile X Syndrome Phenotype J. Mol. Diagn., May 1, 2008; 10(3): 272 - 275. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |